IMATINIB MESYLATE IN THE TREATMENT OF PAEDIATRIC CHRONIC MYELOID LEUKEMIA: A STUDY OF 55 PATIENTS FROM A TERTIARY CARE CANCER CENTRE IN PAKISTAN

被引：0
|
作者：
Rashid, Aqeela [1 ]
Maaz, Ata [2 ]
机构：
[1] Shaukat Khanum Hosp, Lahore, Pakistan
[2] Bristol Royal Hosp Children, Bristol, Avon, England
来源：
PEDIATRIC BLOOD & CANCER | 2012年 / 59卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1038 / 1038
页数：1
相关论文
共 50 条
  • [41] Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia
    Flamant, Stephane
    Ritchie, William
    Guilhot, Joelle
    Holst, Jeff
    Bonnet, Marie-Laure
    Chomel, Jean-Claude
    Guilhot, Francois
    Turhan, Ali G.
    Rasko, John E. J.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (08): : 1325 - 1333
  • [42] Outcome of four patients with chronic myeloid leukemia after imatinib mesylate discontinuation
    Merante, Serena
    Orlandi, Ester
    Bernasconi, Paolo
    Calatroni, Silvia
    Boni, Marina
    Lazzarino, Mario
    HAEMATOLOGICA, 2005, 90 (07) : 979 - 981
  • [43] Chronic myeloid leukemia arising from acute myeloid leukemia: response to imatinib mesylate with favorable outcome
    Xu, Xiao-Hua
    Huang, Lian-Sheng
    Yang, Jing
    Yu, Teng
    Tong, Jie-Feng
    Yuan, Xiang-Gui
    Zhao, Xiao-Ying
    LEUKEMIA & LYMPHOMA, 2013, 54 (01) : 195 - 197
  • [44] How long will chronic myeloid leukemia patients treated with imatinib mesylate live?
    Hasford, J
    Pfirrmann, M
    Hochhaus, A
    LEUKEMIA, 2005, 19 (04) : 497 - 499
  • [45] How long will chronic myeloid leukemia patients treated with imatinib mesylate live?
    J Hasford
    M Pfirrmann
    A Hochhaus
    Leukemia, 2005, 19 : 497 - 499
  • [46] Sudden blastic transformation in patients with chronic myeloid leukemia treated with imatinib mesylate
    Jabbour, E
    Kantarjian, H
    O'Brien, S
    Rios, MB
    Abruzzo, L
    Verstovsek, S
    Garcia-Manero, G
    Cortes, J
    BLOOD, 2006, 107 (02) : 480 - 482
  • [47] Outcome of five patients with chronic myeloid leukemia after imatinib mesylate discontinuation
    Tothova, E.
    Kafkova, A.
    Surova, M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 427 - 427
  • [48] Development of plasma cell leukemia in a patient with chronic myeloid leukemia while on treatment with imatinib mesylate
    Maral, Senem
    Bakanay, Sule Mine
    Yikilmaz, Aysun Senturk
    Dilek, Imdat
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (06) : 1431 - 1433
  • [49] Gene expression signatures associated with treatment and resistance to imatinib mesylate in chronic myeloid leukemia patients.
    Oehler, V
    Branford, S
    Pogosova-Agadjanyan, E
    Shah, N
    Sawyers, C
    Mao, M
    Linsley, P
    Hughes, T
    Radich, J
    BLOOD, 2005, 106 (11) : 131A - 131A
  • [50] MULTIPLE PATHS TO DRUG RESISTANCE PHENOTYPE IN CHRONIC MYELOID LEUKEMIA PATIENTS UNDERGOING IMATINIB MESYLATE TREATMENT
    Ankathil, Ravindran
    Zahry, Mohd Khairi
    Hassan, Rosline
    Dzarr, Abu
    Peng, Hoh Boon
    Baba, Abdul Aziz
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3198 - 3198
12345